Related references
Note: Only part of the references are listed.Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients
Zibo Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Exome sequencing of contralateral breast cancer identifies metastatic disease
Daniel Klevebring et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
Eleonor Olsson et al.
EMBO MOLECULAR MEDICINE (2015)
Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
Yao-Yin Chang et al.
MOLECULAR CANCER (2015)
Advances and Applications of Single-Cell Sequencing Technologies
Yong Wang et al.
MOLECULAR CELL (2015)
Clinical management of breast cancer heterogeneity
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Cancer whole-genome sequencing: present and future
H. Nakagawa et al.
ONCOGENE (2015)
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
Clare Stirzaker et al.
NATURE COMMUNICATIONS (2015)
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Charles Swanton et al.
CANCER DISCOVERY (2015)
Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis
Warwick J. Locke et al.
CLINICAL EPIGENETICS (2015)
Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer
Rohit R. Jadhav et al.
CLINICAL EPIGENETICS (2015)
Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
Nicolas Duployez et al.
EXPERT REVIEW OF HEMATOLOGY (2015)
ARID2: A new tumor suppressor gene in hepatocellular carcinoma
Hong Zhao et al.
Oncotarget (2015)
Contralateral breast cancer can represent a metastatic spread of the first primary tumor: determination of clonal relationship between contralateral breast cancers using next-generation whole genome sequencing
Sara Alkner et al.
BREAST CANCER RESEARCH (2015)
Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics
Amy E. McCart Reed et al.
BREAST CANCER RESEARCH (2015)
Translating Genomics for Precision Cancer Medicine
Sameek Roychowdhury et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 15 (2014)
Recurrent read-through fusion transcripts in breast cancer
Katherine E. Varley et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
A systematic description of MLL fusion gene formation
Rebecca L. Wright et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Breast cancer: Current and future endocrine therapies
Carlo Palmieri et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Yong Wang et al.
NATURE (2014)
Expanding the computational toolbox for mining cancer genomes
Li Ding et al.
NATURE REVIEWS GENETICS (2014)
Mining cancer methylomes: prospects and challenges
Clare Stirzaker et al.
TRENDS IN GENETICS (2014)
MicroRNAs in cancer: biomarkers, functions and therapy
Josie Hayes et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Justin M. Balko et al.
CANCER DISCOVERY (2014)
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
Nicole M. Davis et al.
ONCOTARGET (2014)
Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients
Shanye Yin et al.
SCIENTIFIC REPORTS (2014)
Next-Generation Sequencing in Clinical Oncology: Next Steps Towards Clinical Validation
Nigel C. Bennett et al.
CANCERS (2014)
Opportunities and methods for studying alternative splicing in cancer with RNA-Seq
Huijuan Feng et al.
CANCER LETTERS (2013)
D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
Keren Merenbakh-Lamin et al.
CANCER RESEARCH (2013)
Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma
Gilles Manceau et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
KRAS Mutations as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer
Petra Martin et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
Leticia De Mattos-Arruda et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The RUNX family in breast cancer: relationships with estrogen signaling
N-O Chimge et al.
ONCOGENE (2013)
Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
Jennifer N. Wu et al.
CANCER DISCOVERY (2013)
Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies
Clare Davies et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Chimeric RNAs as potential biomarkers for tumor diagnosis
Jianhua Zhou et al.
BMB REPORTS (2012)
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel-Wahab et al.
CANCER CELL (2012)
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Pilar Eroles et al.
CANCER TREATMENT REVIEWS (2012)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Cancer epigenomics: beyond genomics
Juan Sandoval et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
DNA methylation biomarkers in cancer: progress towards clinical implementation
Thomas Mikeska et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases
Veronique Gelsi-Boyer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Whole-genome analysis informs breast cancer response to aromatase inhibition
Matthew J. Ellis et al.
NATURE (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Evolution of the cancer genome
Lucy R. Yates et al.
NATURE REVIEWS GENETICS (2012)
Gene Fusions Associated with Recurrent Amplicons Represent a Class of Passenger Aberrations in Breast Cancer
Shanker Kalyana-Sundaram et al.
NEOPLASIA (2012)
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
Klaus H. Metzeler et al.
BLOOD (2011)
Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer
Sally J. Davis et al.
BMC CANCER (2011)
DNA methylation in early neoplasia
F. Javier Carmona et al.
CANCER BIOMARKERS (2011)
Identification of New MicroRNAs in Paired Normal and Tumor Breast Tissue Suggests a Dual Role for the ERBB2/Her2 Gene
Helena Persson et al.
CANCER RESEARCH (2011)
MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
Thalia A. Farazi et al.
CANCER RESEARCH (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Dan R. Robinson et al.
NATURE MEDICINE (2011)
Integrated Analysis of Gene Expression, CpG Island Methylation, and Gene Copy Number in Breast Cancer Cells by Deep Sequencing
Zhifu Sun et al.
PLOS ONE (2011)
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Henrik Edgren et al.
GENOME BIOLOGY (2011)
Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing
Yoshinao Ruike et al.
BMC GENOMICS (2010)
MicroRNA-21 A novel therapeutic target in human cancer
Xuan Pan et al.
CANCER BIOLOGY & THERAPY (2010)
Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon
Thanemozhi G. Natarajan et al.
CANCER CELL INTERNATIONAL (2010)
LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer
Yoon-La Choi et al.
CANCER RESEARCH (2010)
Genome-Wide Analysis of Estrogen Receptor α DNA Binding and Tethering Mechanisms Identifies Runx1 as a Novel Tethering Factor in Receptor-Mediated Transcriptional Activation
Joshua D. Stender et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Modulation of the Tumor Suppressor Protein α-Catenin by Ischemic Microenvironment
Claire L. Plumb et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Loss of α-Catenin Decreases the Strength of Single E-cadherin Bonds between Human Cancer Cells
Saumendra Bajpai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prediction of cancer driver mutations in protein kinases
Ali Torkamani et al.
CANCER RESEARCH (2008)
Basal-like breast cancer: A critical review
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression
Jian-Hua Mao et al.
SCIENCE (2008)
The AID/APOBEC family of nucleic acid mutators
Silvestro G. Conticello
GENOME BIOLOGY (2008)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
Fbw7 isoform interaction contributes to cyclin E proteolysis
Wei Zhang et al.
MOLECULAR CANCER RESEARCH (2006)
Core-binding factor β interacts with Runx2 and is required for skeletal development
CA Yoshida et al.
NATURE GENETICS (2002)
Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation
HS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Core binding factor and its role in normal hematopoietic development
NA Speck
CURRENT OPINION IN HEMATOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
